Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diagnosing Acidosis and Alkalosis01:24

Diagnosing Acidosis and Alkalosis

1.2K
Diagnosing acid-base imbalances involves systematically analyzing arterial blood samples, focusing on three key measurements: pH, bicarbonate (HCO3−) concentration, and carbon dioxide partial pressure (PCO2). This analysis follows a four-step process that helps identify the imbalance's underlying cause and nature.
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2  and...
1.2K
Patient-centered Care01:13

Patient-centered Care

3.0K
Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
3.0K
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

232
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
232
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

254
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
254
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

202
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
202
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

225
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
225

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Chronic cystitis: how to prolong the relapse-free period?]

Urologiia (Moscow, Russia : 1999)·2023
Same author

[Impact of the SARS-CV-2 virus on the urinary bladder].

Urologiia (Moscow, Russia : 1999)·2023
Same author

[Dynamics of the structure of renal tuberculosis over 20 years].

Terapevticheskii arkhiv·2023
Same author

[Combined therapy of patients with recurrent cystitis using a complex of natural antimicrobial peptides and cytokines: first results].

Urologiia (Moscow, Russia : 1999)·2023
Same author

[Tuberculosis of the male genital organs].

Urologiia (Moscow, Russia : 1999)·2023
Same author

[Epithelial protective therapy in comorbid diseases. Practical Guidelines for Physicians].

Terapevticheskii arkhiv·2022

Related Experiment Video

Updated: Jan 29, 2026

Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia Using a 980 nm Diode Laser
05:28

Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia Using a 980 nm Diode Laser

Published on: May 5, 2020

2.7K

[Patients with newly diagnosed benign prostatic hyperplasia].

I O Meshkov1,2,3, E V Kulchavenya1,2,3, S Yu Shevchenko1,2,3

  • 1Novosibirsk TB Research Institute of Minzdrav of Russia, Novosibirsk, Russia.

Urologiia (Moscow, Russia : 1999)
|February 15, 2019
PubMed
Summary

Benign prostatic hyperplasia (BPH) affects over a quarter of urology patients. Older men experience more severe BPH symptoms, but younger men have longer disease duration before diagnosis.

Keywords:
BPHbenign prostatic hyperplasiadiagnosticsepidemiologyprostatitis

More Related Videos

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.
06:04

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.

Published on: March 6, 2018

17.6K
Renal Capsule Xenografting and Subcutaneous Pellet Implantation for the Evaluation of Prostate Carcinogenesis and Benign Prostatic Hyperplasia
08:38

Renal Capsule Xenografting and Subcutaneous Pellet Implantation for the Evaluation of Prostate Carcinogenesis and Benign Prostatic Hyperplasia

Published on: August 28, 2013

26.1K

Related Experiment Videos

Last Updated: Jan 29, 2026

Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia Using a 980 nm Diode Laser
05:28

Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia Using a 980 nm Diode Laser

Published on: May 5, 2020

2.7K
Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.
06:04

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.

Published on: March 6, 2018

17.6K
Renal Capsule Xenografting and Subcutaneous Pellet Implantation for the Evaluation of Prostate Carcinogenesis and Benign Prostatic Hyperplasia
08:38

Renal Capsule Xenografting and Subcutaneous Pellet Implantation for the Evaluation of Prostate Carcinogenesis and Benign Prostatic Hyperplasia

Published on: August 28, 2013

26.1K

Area of Science:

  • Urology
  • Andrology
  • Gerontology

Background:

  • Benign prostatic hyperplasia (BPH) is a common condition in aging men.
  • Understanding patient characteristics and diagnostic patterns is crucial for timely intervention.

Purpose of the Study:

  • To characterize patients with newly diagnosed benign prostatic hyperplasia (BPH).
  • To identify factors contributing to delayed diagnosis of BPH.

Main Methods:

  • Retrospective analysis of 165 patients with newly diagnosed BPH from outpatient urological records.
  • Data collected included patient demographics, disease duration, prostate volume, PSA levels, and International Prostate Symptom Score (IPSS).

Main Results:

  • BPH was diagnosed in 27.1% of 3544 patients seeking urological care.
  • Disease duration increased with age, with longer durations in older men (over 70 years).
  • Prostate volume, PSA levels, and IPSS generally increased with age, with peak symptom severity in the 61-70 age group.

Conclusions:

  • BPH is prevalent among patients seeking urological care.
  • While older men have more severe symptoms, younger men experience longer disease duration before seeking care.
  • Marital status influenced healthcare-seeking behavior, with married men presenting with less severe symptoms.